Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H.B.M. Schreuder, Catharina J.M. Klijn, Michel Remmers et al.|The Lancet Neurology|2021Cited by 101
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trialCatharina J.M. Klijn, Ale Algra, Roger E. G. Schutgens et al.|Trials|2015Cited by 66